Programme : Back to Dr Dan Gare

Fibrinogen targeted Affimers can successfully modulate fibrin clot lysis in the presence of plasminogen inhibitor


Cardiovascular disease remains the main cause of morbidity and mortality in the developed world. Fibrin clot structure and fibrinolysis can determine predisposition to CVD and manipulating the prothrombotic environment can reduce the risk of vascular events. Current treatment strategies are only partially effective at reducing the thrombotic milieu, and frequently associated with adverse events secondary to bleeding. Identification of new therapeutic targets is necessary to reduce thrombosis potential in high risk subjects.

Add to favourites

Hosted By
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
iPhone App
Android App
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2018